Hsp 60 is a chaperonin protein, homologous to GroEL of Escherichia coli and highly conserved across species. Immune response induced by the hsp 60 equivalent of numerous microorganisms elicits in animals and man a dominant cross-reactive T lymphocyte response. Hsp 60 has been strongly implicated as an example of molecular mimicry in the pathogenicity of autoimmune diseases and, more recently, in T cell-mediated protection. Curiously, in spite of this interest, the gene encoding HSP 60 has not yet been cloned. Sequencing of numerous PCR-derived HSP 60 clones, obtained following amplification of genomic DNA revealed multiple distinct but highly related sequences. These were all different from the sequence encoding the expressed protein and all had interrupted reading frames. PCR amplification from mRNA, however, yielded only the sequence expected for the expressed hsp 60 protein. This apparent paradox was resolved by cloning and sequencing HSP 60-specific genomic clones: the majority of these clones corresponded to intronless genes having the characteristics of retro-pseudogenes and were flanked by unrelated DNA sequences. In addition, several genomic clones were isolated that corresponded to a unique functional HSP 60 gene. This gene is composed of multiple exons, some very short. The transcription start site was identified and 750 bp of 5' flanking sequence were determined. The human HSP 60 gene is induced by heat. We conclude that hsp 60 is encoded by a single highly fragmented gene, that co-exists with multiple HSP 60 retro-pseudogenes, normally not expressed.
Introduction
Hsp 60 is a mammalian heat shock protein known to function as an essential chaperonin (1, 2) . It has an important role in protein folding and in transport within mitochondria (3) . Human hsp 60 is homologous to the Escherichia coli protein GroEL (4) (5) (6) (7) (8) , also an important chaperonin, and to the yeast mif4 protein (9) . The mechanism of action of GroEL has been studied in detail (10) (11) (12) (13) . It is one of the most highly conserved protein in both pro-and eukaryotes Recently, a cytosolic GroEL homologue, distinct from mitochondrial hsp 60, has been identified (6, 14, 15) . It is quite different in structure from the HSP 60 gene discussed in this paper.
In addition to its essential role as a chaperonin, hsp 60 has received much attention as a dominant cross-reactive antigen and has been implicated in the pathogenesis of autoimmune diseases (reviewed in 16, 17) . The hsp 60 homologous proteins from several microorganisms, including frequent human pathogens, such as Mycobacterium tuberculosis, elicit a strong and dominant immune response in their mammalian hosts (18) (19) (20) . Because of the extensive sequence conservation of the hsp 60 protein in pro-and eukaryotes, hsp 60-specific cross-reactive T cells are generated in several animal species, capable of recognizing distinct epitopes of the human hsp 60 protein (21) Furthermore, in the case of several animal experimental autoimmune models, such hsp 60-specific T cells were found able to transfer the disease upon injection into healthy animals (22) (23) (24) . The possible implication of hsp 60 in the pathogenicity of autoimmune diabetes and arthritis was further strengthened by claims of induction of the diseases by specific hsp 60 peptides (25) and of vaccination against diabetes by such hsp 60 peptides (26) (27) (28) . Very recently, it was reported that activation of T cells that recognize a specific MHC class II restricted epitope of hsp 60 can protect against adjuvant arthritis (29) . This important observation implies that cross-reactivity to self hsp 60 epitopes might be involved in T cell-mediated protection against autoimmune diseases, a concept that implies a re-evaluation of the role of hsp 60 in immunopathology It is not known to what extent the hsp 60 chaperonin may be implicated in the processing and/or the transport of antigens towards MHC-mediated antigen presentation.
In spite of this interest in hsp 60, both as a chaperonin and as a cross-reactive antigen possibly involved in autoimmune diseases, the gene encoding HSP 60 has not been cloned. This situation is probably a consequence of the genetic complexity of HSP 60 genes presented in this paper. Indeed, we have identified and cloned multiple non-expressed HSP 60 pseudogenes, without introns, probably representing retroposons, as well as a single expressed HSP 60 gene, with multiple introns. It has been previously assumed that, by analogy with other HSP genes such as HSP 70, the HSP 60 gene did not contain introns (30, 31) . These data now open the way to functional studies on the regulation of HSP 60 gene expression and to molecular studies exploring a possible genetic linkage between HSP 60 locus and disease susceptibility.
Methods

Preparation of DNA
DNA was extracted from peripheral blood lymphocytes or culture cell lines according to the procedure of Gros-Bellard et al (32) with minor modifications described by Tiercy et al. (33) without DNA dialysis.
Amplification of genomic DNA
DNA samples (1 ng) were amplified by PCR, in a 50 JLXI reaction using Taq polymerase (1 unit per reaction, Boehringer Mannheim, Rotkreuz, Switzerland). The PCR reactions were carried out with 50 pmol of primers, 200 |iM dNTP, 2 mM MgCI 2 and 1 xPCR buffer containing 50 mM KCI, 10 mM Tris, pH 8 4, 100 ng/ml BSA. Twenty five cycles of amplifications were performed on the programmable thermocycler (Techne PHC-1) in which each cycle consists of 1 mm at 94°C, 30 s at 55°C and 30 s at 72°C
Subclonmg and sequencing of PCR products
The PCR products were extracted with phenol-chloroform, precipitated with ethanol and dissolved in water. Pst\ and H/ndlll restriction sites, incorporated into the 5' and 3' primers respectively, enable the amplified products to be subcloned into the Bluescript vectors (Stratagene, Heidelberg, Germany) One quarter of the amplified product was transformed into competent JM103 cells. The DNA sequence of the transformed clones was determined directly on the doublestranded clones by the dideoxy chain termination method (34) using the T7 enzyme system (Pharmacia).
Probes used for filters hybridizations
A fragment of 1.3 kb, obtained by genomic amplification with the primer Hsp5' and Hsp6 2, subcloned and entirely sequenced, was used as a probe (F1) and 32 P-labeled by random primed synthesis. This fragment corresponds to an HSP 60 pseudogene. The oligonucleotides probes were 5' end labeled with [ 32 P]ATP and polynucleotide kinase. Oligonucleotides sequences:
Southern analysis
Genomic DNA was isolated from cultured HeLa cells and 15 ng sample were digested to completion by one or several restriction enzymes. After electrophoresis on 0 7% agarose gels, the DNA was transferred to Gene Screen Plus membranes according to the suggestions of the manufacturer (NEN, Regensdorf, Switzerland). The blots were hybridized to the F1 probe with a sp. act of 1 5X10 6 c.p.m/ml The hybridization conditions were 50% formamide, 10xDenhardt's, 1 M NaCI, 1% SDS, 50 mM Tris, pH 7.5, 200 ng/ml herring sperm DNA at 42°C The filters were washed in 1 xSSC at 65°C.
Preparation of RNA
Total RNA was extracted from frozen cell pellets by using guanidium isothiocyanate (34) and poly(A) + RNA was purified by oligo(dT)-cellulose chromatography. The nuclear and cytoplasmic RNA were extracted from Raji and THP1 cell lines by the method described by M. Wilkinson (35) PCR on total RNA Total RNA was treated with DNase I, 30 min at 37°C. The first strand of the cDNA was obtained by reverse transcnptase reaction on 50 u.g of total RNA in a volume of 50 JLLI with 100 pmol of random hexanucleotides, 500 nM of each dNTP, 32 units of RNase Inh. (Biofinex, Praroman, Switzerland) and 200 units of MMLV reverse transcnptase (BRL, Basel, Switzerland) in ixreverse transcnptase buffer (BRL) The reaction was earned out 1 h at 42°C, heated at 95°C and twice precipitated to eliminate the non-incorporated primers. Half of the reverse transcript product was amplified with the primers Hsp5.1/Hsp5.2 as described for the genomic PCR. The amplified products were subcloned and sequenced.
PCR on nuclear and cytoplasmic RNA
The first strands of the cDNAs were synthesized as mentioned before on 5 ng of RNA pretreated by DNase I. The PCR were carried out with the primers Hsp5' and Hsp6.2 under the same conditions used for genomic DNA.
Contamination of RNA samples with DNA was tested by direct amplification on 5 u.g of the same RNA preparation without reverse transcription
The amplified products were separated on 1% agarose gels and hybridized directly in the gel, as described by Ugozzoh et al. (36) , with the 5'-end-labeled oligo Hsp254A.
Screening of a human genomic library
A human partial Sau3A genomic library cloned in EMBL3 (generously provided by Catherine Nguyen, INSERM) was screened with the F1 probe and the specific oligonucleotide Hsp254A.
Filters were hybridized to the 32 P-labeled F1 probe The hybridization conditions were 4xSSC, 5xDenhardt's, 0.1% SDS, 5 mM EDTA, 10 mM NaP and 100 jig/ml of herring sperm DNA at 68°C overnight. Filters were washed at final stringency in 0 1 xSSC at 68°C.
The 5'-end-labeled Hsp254A was added to 5xSSC, 20 mM NaP, 10xDenhardt's, 5% SDS and 200 jig/ml of herring sperm DNA at 50°C
Positively hybridizing recombinant phages were plaque purified, and phage DNA was prepared. A restriction map was determined with the enzymes Sa/I, EcoRI and BamHI. The genomic inserts were subcloned in the Bluescript vector and their sequences determined with the specific oligonucleotides derived by the cDNA sequence
Primer extension
For primer extension analysis, the Hsp65+9F and Hsp65+80 oligonucleotide primers complementary to a sequence within + RNA and total RNA, digestion with RNase A and T1, and PAGE were done as described previously (37) .
Results
Evidences for a family of HSP 60 genes
The DNA sequence analysis of the clones obtained after PCR amplification of human DNA with several sets of HSP 60-specific primers gave unexpected results. Primers Hsp5' and Hsp6 2 delimited a cDNA fragment of 1.3 kb and primers Hsp5.1 and Hsp5.2 a fragment of 260 bp; coding for a portion of the hsp 60 protein that contains a well-studied immunoreactive T cell epitope (38, 39) . Two separate PCR amplifications were performed with each primer pair, on DNA prepared from nine different unrelated individuals. PCR amplification was performed under conditions tested to minimize polymerase-induced nucleotide substitution. All PCR products, when analyzed by agarose gel electrophoresis, corresponded to the expected cDNA size (data not shown).
Amplified DNA was subcloned and sequenced. From the product of the Hsp5.1 and Hsp5.2 primers, 64 different clones were sequenced, some several times, and this revealed an extensive sequence diversity and allowed the identification of 25 distinct highly homologous sequences (Fig 1B) . A
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striking feature of all these sequences was that none of them corresponded to the HSP 60 cDNA sequence! All the different sequences obtained from genomic DNA differed from cDNA by one or multiple nucleotide substitutions. Five of these different sequences (referred to as I, II, III, IV and V in Fig.  1B) were observed in the DNA from each of the nine individuals studied Nine positions (at nucleotides 599, 651, 661, 666, 741, 760,769,803, and 816 according to the cDNA sequence) were preferentially mutated. The mutation at position 661 (C to T) creates a stop codon. Other stop codons were observed in the PCR products of 1.3 kb, resulting from the deletion of one nucleotide at position 1266 or 1405 (data not shown). As a result of one these interruptions in the reading frame, it appears that none of these multiple HSP 60 genomic sequences can encode for a full length protein. Sequencing of multiple clones obtained from several independent PCR amplifications of the same genomic DNA confirmed that the observed diversity in HSP 60 DNA sequences was not the result of PCR artifacts (data not shown). Surprisingly, all these different clones are characterized by the presence, at position 760 of the cDNA sequence, of a G instead of an A (Fig. 1 ). All sequences were performed on both DNA strands and confirmed following a second PCR amplification.
These data suggest the existence, in human DNA, of a family of HSP 60 pseudogenes. This was confirmed by Southern blot hybridization (Fig. 2) . DNA was digested with the enzymes SamHI, EcoRI and Pstt. Hybridization reveals multiple HSP 60-specific fragments of various sizes. It is likely that the variation in the signal intensity of the different bands results from sequence divergence and/or from the existence of pseudogene clusters. 
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Expression of a single HSP 60 RNA sequence
The analysis of expressed HSP 60 transcripts by Northern blots was performed either with a 1.3 kb probe (obtained by PCR from genomic DNA, see above) or with oligonucleotides specific of the cDNA sequence around position 760, and containing either A (Hsp254A) or G, like all pseudogenes (Hsp254G). Northern blots showed a single HSP 60 mRNA band of 2.3 kDa, hybridizing with both the cDNA probe and the Hsp254A oligonucleotide, while no signal was obtained with the Hsp254G oligonucleotide (data not shown) This indicates that only the HSP 60 gene with A at position 760 is expressed and none of the pseudogenes.
PCR amplification was then performed on cDNA prepared from cytoplasmic RNA from different individuals using primers Hsp5.1 and Hsp5 2. The amplified fragments were subcloned and 16 such subclones were sequenced. In contrast to our finding with genomic DNA, all HSP 60 sequences derived from mRNA were identical to the published cDNA sequence, including the A at position 760. None of the multiple genomic HSP 60 sequences identified earlier corresponded to that cDNA sequence (Fig. 1) . In addition, the RT-PCR product was hybridized with the Hsp254A and the Hsp254G oligonucleotide probes Again, hybridization was positive with the probe specific for the expressed gene, while no signal was obtained with the pseudogene probe Hsp254G (data not shown)
Evidence for an unsphced nuclear form of HSP 60 RNA
To resolve the apparent paradox of the multiple mutated HSP 60 genes, we looked for the presence of unspliced nuclear HSP 60 transcripts. PCR was performed on cDNA prepared from either nuclear or cytoplasmic RNA and the resulting amplification product analyzed by Southern blot, .using an oligonucleotide probe (Hsp254A). As shown in Fig. 3, a 1.3 kb PCR product, corresponding in length to the HSP 60 cDNA, was observed in both the cytoplasmic and nuclear RNA. In nuclear RNA, however, a larger RNA (2 1 kb) was present, indicative of an incompletely spliced HSP 60 transcript.
Isolation and characterization of the expressed HSP 60 gene
Considering the previous data, it could be argued that the expressed HSP 60 gene should have introns and be characterized by the presence of an A at position 760. In order to isolate the expressed HSP 60 gene, >1x10 6 phages from a non-amplified human genomic library were screened in duplicate with the 1.3 kb HSP 60 probe (obtained by amplification of genomic DNA). After three rounds of hybridization, 45 phages were isolated. Three of these (28C1, 28C2 and 28C3) hybridized specifically with oligonucleotide Hsp254A, suggesting that these clones corresponded to the expressed HSP 60 gene The other 42 phages all hybridized to the Hsp254G oligonucleotide, as expected from signals derived from the HSP 60 pseudogenes Sequence analysis of selected clones among these 42 phages indicated that they indeed contain the various HSP 60 sequences previously identified in amplified genomic DNA (Fig. 1) , including the characteristic stop codons. Importantly the DNA sequences flanking these intronless pseudogenes are all different (see below). 
Promoter of the HSP 60 gene and initiation site
Because of the potential importance of the regulation of HSP 60 gene expression in immunopathology, the exact nature of the initiation site and the structure of the HSP 60 promoter were investigated. The transcription initiation site of the expressed HSP 60 gene was identified by primer extension and RNase protection experiments. For primer extension, we used a synthetic 19-mer (Hsp65+9), nine nucleotides downstream of the ATG. As shown in Fig 6, oligo Hsp65+9 primed the synthesis of a major product extending 62 nucleotides within exon 1. Other weaker products corresponded to extension of 56, 68, 70 and 88 nucleotides into exon 1 (Fig.  6) , and reflect additional minor start sites. To confirm this result, RNase protection assays were performed using the same RNAs. A genomic fragment of 443 bp, containing the promoter region, the first exon (E1) and 167 bp of the first intron, was used to generate a labeled RNA probe in vitro. . RNase protection using a Nae\ (N)-SamHI (B) fragment containing the promoter, the first exon (E1) and 187 bp of the first intron (11) major initiation site (+1) is indicated on the map as well as on the sequence of the HSP 60 promoter in Fig. 8 . About 750 nucleotides upstream of the HSP 60 transcription initiation sites were sequenced. This region was compared with the 5' flanking sequence of several cloned pseudogenes The entire transcribed region, including the 5' untranslated region, shows extensive homology to the HSP 60 pseudogenes examined (98%). For each pseudogene the sequence homology extends up to one of the initiation site predicted by the previous experiment. Upstream of this transcription start site, the sequences are totally divergent, indicating that all these different HSP 60 genes reside indeed in different DNA contexts (see example in Fig. 8A) .
The HSP 60 gene promoter is characterized by the absence of a classical TATAA box and by the presence of a single heat shock response element (HSE), nGAAn, located 233 bp upstream of the major initiation site (Fig. 8B) . Promoters of other heat shock protein genes frequently contain several such elements (40) (41) (42) . Two potential Sp1 sites are also present 64 and 150 bp upstream from the major initiation site.
In agreement with earlier studies on the inducibility of the HSP 60 gene by heat (43), we confirmed by Northern blot experiment that HSP 60 mRNA is indeed induced in several cell types following exposure to 42°C (data not shown).
Discussion
The chaperonin hsp 60, the mammalian homologue of the GroEL of E. coli, is of interest to cell biologists because of its essential role as a catalyst of protein folding At the same time, the well-documented dominant cross-reactive immune response to bacterial hsp 60 in various animal models has made hsp 60 an interesting candidate as an auto-antigen in the pathogenicity of autoimmune diseases (39, 44) In fact, it has been demonstrated that hsp 60-specific CD4 T cells, elicited in different animal species by bacterial hsp 60, react to specific epitopes of mammalian hsp 60, including human hsp 60 (25, (45) (46) (47) . Furthermore, the fact that such hsp 60-specific T cell lines or clones can trigger autoimmune diabetes or arthritis in healthy animals by passive transfer (23) has strengthened the models implicating hsp 60 in these diseases Finally, it has been claimed that specific hsp 60 peptides, corresponding to the epitope recognized by T cells, could induce autoimmune arthritis or diabetes in rat and mouse (25) , whereas the same peptides, when administered as tolerogens, could protect, or vaccinate, against the same autoimmune diseases (26) . Although these last experiments have not been generally reproduced, the role of hsp 60 epitopes as dominant cross-reactive T cell antigens and the functional role of such hsp 60-specific T cells in transferring autoimmune diseases is generally accepted. The recent demonstration of protection against adjuvant arthritis by T lymphocytes that specifically recognize an hsp 60 epitope (29) suggests yet a different, or additional, role for hsp 60 cross-reactivity and may lead us to reconsider the role of hsp 60 in the pathogenesis of autoimmune diseases.
It is therefore quite surprising that, in spite of such a general interest for hsp 60 in cell biology and in immunopathology, the HSP 60 gene had not been cloned. The extensive genetic complexity of HSP 60 genes reported here, as well as the finding that, contrary to earlier assumptions and to the case of other HSP genes, the HSP 60 gene contains multiple introns, probably explain earlier failure to identify this gene.
Our initial studies confronted us with a paradox: (i) multiple different HSP 60 sequences were identified following amplification of genomic DNA, none of which corresponded to the expressed HSP 60 sequence, and (ii) from mRNA (and cDNA), however, amplification lead exclusively to the expressed HSP 60 sequence. The data reported here explain these findings on the basis of multiple intronless pseudogenes, scattered in the human genome, and of a single expressed HSP 60 containing multiple introns. From genomic DNA, the numerous intronless pseudogenes are preferentially amplified by PCR, whereas expressed mRNA contains exclusively the processed product of the unique expressed, intron-containing, HSP 60 gene. There is no evidence for expression of any of the HSP 60 pseudogenes, characterized by a G at position 760. Earlier attempts at cloning the HSP 60 gene had lead to pseudogenes and the report suggesting expression of hsp 60 from an intronless gene (48) (49) (50) should probably be re-evaluated on the basis of the findings reported here We have not attempted to quantify the number of HSP 60 pseudogenes, but the screening of the genomic library suggests the presence of at least 15 such genes. The existence of numerous pseudogenes in the mammalian genome has been observed in the case of several other genes (51-53), generally housekeeping genes, but also in the case of the HSP 70 gene (54, 55) It is generally believed that such pseudogenes result from multiple retroposition events, involving reverse transcription of cellular mRNA and probably mediated by a retrovirus (56) . Why the 5' untranslated region of the HSP 60 pseudogenes, which is presumably not subjected to selection pressure, is conserved in sequence and has remained identical to that of the expressed gene is not clear and represents an unsuspected observation.
Although there is no obvious precedent described, we would like to suggest the possibility that rare gene rearrangements or chromosomal translocations could involve one of the multiple HSP 60 pseudogenes and lead to transcriptional activation of all or part of its sequence. This could result in the synthesis of a fusion or truncated protein, as documented in the case of other gene rearrangements (56) . Since hsp 60 is a strongly immunogenic protein, it is interesting to speculate that such an aberrant expression of a modified and truncated form of hsp 60 peptides, encoded by a pseudogene, could lead to aberrant immunoreactivity with pathological consequences.
In addition to the lack of introns and to their sequence diversity, the multiple HSP 60 pseudogenes are characterized by a G at position 760, whereas the HSP 60 cDNA has an A at that same position. We used this property of the expressed HSP 60 sequence as a tool for the identification of the genomic clones containing the expressed HSP 60 gene, in the context of a large excess of clones corresponding to pseudogenes Interestingly, other mammalian HSP 60 cDNAs have a G at position 760 (48) (49) (50) 57) , unlike the human cDNA, but like the human pseudogenes. We therefore suggest that the generation of all the pseudogenes came first and that subsequently, in man, the G to A substitution took place at the expressed HSP 60 locus In that prospect, it will be interesting to analyze if the HSP 60 genes of other primates have an A or a G at position 760 in the expressed HSP 60 gene.
Because of the obvious biological interest of the regulation of expression of the HSP 60 gene, we have analyzed the structure of its promoter and identified the transcription initiation sites. Like in the promoter of most housekeeping genes, there is no obvious TATAA box in the HSP 60 promoter, nor a CAT box. Other HSP genes do have a TATAA and a CAT box (58) The presence of two Sp1 sites in the HSP 60 promoter might play a role in recruiting other required transcription factors, as suggested in other cases (59) . We have also detected typical HSE motives, palindromes involving the consensus sequence nGAAn and known to be the targets for the binding of factor HSF (60) . In the HSP 60 promoter, there are four such sequences in tandem around position -219 to -233 (Fig. 7) , forming two adjacent palindromes. The position of the HSE motives is more distant from the initiation site than in the HSP 70 promoter and in the latter, two HSE palindromes are separated by 20 bp (41) The human HSP 60 gene is indeed induced by heat shock. The availability of the DNA sequence of the HSP 60 promoter will now make it possible to study the molecular mechanism controlling this induction
The elucidation of the genetic complexity of the human HSP 60 gene opens the way to a number of different studies. Genetic linkage analysis can now be considered in order to correlate HSP 60 gene expression with disease susceptibility, in particular in the case of human and mouse insulin-dependent diabetes. The possibility of a disregulation of expression of the HSP 60 gene in particular tissues in various disease situations, as well as the search for functionally relevant polymorphic changes within the promoter can be considered.
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Indeed, fluctuations in the magnitude of the hsp 60 response could result in aberrant immune responses and immunopathology. By homologous recombination and transgenic experiments, it will now also be possible to modify the normal HSP 60 sequence, or its pattern of expression in vivo, and study the pathological consequences.
